PubMed

Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.

Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter HB, Metter EJ, Chen C, Weiss NS, Fitzpatrick A, Hsing AW, Lacey JV Jr, Helzlsouer K, Rinaldi S, Riboli E, Kaaks R, Janssen JA, Wildhagen MF, Schröder FH, Platz EA, Pollak M, Giovannucci E, Schaefer C, Quesenberry CP Jr, Vogelman JH, Severi G, English DR, Giles GG, Stattin P, Hallmans G, Johansson M, Chan JM, Gann P, Oliver SE, Holly JM, Donovan J, Meyer F, Bairati I, Galan P.

Ann Intern Med. 2008 Oct 7;149(7):461-71, W83-8.PMID: 18838726 [PubMed - indexed for MEDLINE]Related articlesFree article

Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.

Stattin P, Bylund A, Rinaldi S, Biessy C, Déchaud H, Stenman UH, Egevad L, Riboli E, Hallmans G, Kaaks R.

J Natl Cancer Inst. 2000 Dec 6;92(23):1910-7.PMID: 11106682 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.

Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, Rinaldi S, Zeleniuch-Jacquotte A, Shore RE, Riboli E.

J Natl Cancer Inst. 2000 Oct 4;92(19):1592-600.PMID: 11018095 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin-like growth factors and prostate cancer: a population-based case-control study in China.

Chokkalingam AP, Pollak M, Fillmore CM, Gao YT, Stanczyk FZ, Deng J, Sesterhenn IA, Mostofi FK, Fears TR, Madigan MP, Ziegler RG, Fraumeni JF Jr, Hsing AW.

Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):421-7.PMID: 11352850 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.

Chan JM, Stampfer MJ, Ma J, Gann P, Gaziano JM, Pollak M, Giovannucci E.

J Natl Cancer Inst. 2002 Jul 17;94(14):1099-106.PMID: 12122101 [PubMed - indexed for MEDLINE]Related articlesFree article

The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery.

Cotterill AM, Mendel P, Holly JM, Timmins AG, Camacho-Hübner C, Hughes SC, Ross RM, Blum WF, Langford RM.

Clin Endocrinol (Oxf). 1996 Jan;44(1):91-101.PMID: 8706300 [PubMed - indexed for MEDLINE]Related articles

Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.

Schernhammer ES, Holly JM, Pollak MN, Hankinson SE.

Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):699-704.PMID: 15767352 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study.

Wolk A, Mantzoros CS, Andersson SO, Bergström R, Signorello LB, Lagiou P, Adami HO, Trichopoulos D.

J Natl Cancer Inst. 1998 Jun 17;90(12):911-5.PMID: 9637140 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum insulin-like growth factors and their binding proteins in children with end-stage renal disease.

Tönshoff B, Blum WF, Mehls O.

Pediatr Nephrol. 1996 Jun;10(3):269-74.PMID: 8792388 [PubMed - indexed for MEDLINE]Related articles

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ.

J Natl Cancer Inst. 1999 Apr 7;91(7):620-5.PMID: 10203281 [PubMed - indexed for MEDLINE]Related articlesFree article

Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer.

Severi G, Morris HA, MacInnis RJ, English DR, Tilley WD, Hopper JL, Boyle P, Giles GG.

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1137-41.PMID: 16775172 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer.

Harman SM, Metter EJ, Blackman MR, Landis PK, Carter HB; Baltimore Longitudinal Study on Aging.

J Clin Endocrinol Metab. 2000 Nov;85(11):4258-65.PMID: 11095464 [PubMed - indexed for MEDLINE]Related articlesFree article

A prospective study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in women.

Lukanova A, Toniolo P, Akhmedkhanov A, Biessy C, Haley NJ, Shore RE, Riboli E, Rinaldi S, Kaaks R.

Int J Cancer. 2001 Jun 15;92(6):888-92.PMID: 11351312 [PubMed - indexed for MEDLINE]Related articles

Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation.

Yu H, Mistry J, Nicar MJ, Khosravi MJ, Diamandis A, van Doorn J, Juul A.

J Clin Lab Anal. 1999;13(4):166-72.PMID: 10414596 [PubMed - indexed for MEDLINE]Related articles

Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition.

Allen NE, Key TJ, Appleby PN, Travis RC, Roddam AW, Rinaldi S, Egevad L, Rohrmann S, Linseisen J, Pischon T, Boeing H, Johnsen NF, Tjønneland A, Grønbaek H, Overvad K, Kiemeney L, Bueno-de-Mesquita HB, Bingham S, Khaw KT, Tumino R, Berrino F, Mattiello A, Sacerdote C, Palli D, Quirós JR, Ardanaz E, Navarro C, Larrañaga N, Gonzalez C, Sanchez MJ, Trichopoulou A, Travezea C, Trichopoulos D, Jenab M, Ferrari P, Riboli E, Kaaks R.

Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1121-7.PMID: 17548673 [PubMed - indexed for MEDLINE]Related articlesFree article

Relation of serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 to risk of prostate cancer (United States).

Li L, Yu H, Schumacher F, Casey G, Witte JS.

Cancer Causes Control. 2003 Oct;14(8):721-6.PMID: 14674736 [PubMed - indexed for MEDLINE]Related articles

Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis.

Rowlands MA, Gunnell D, Harris R, Vatten LJ, Holly JM, Martin RM.

Int J Cancer. 2009 May 15;124(10):2416-29. Review.PMID: 19142965 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBP-1, -2 and -3) in diabetic pregnancy: relationship to macrosomia.

Yan-Jun L, Tsushima T, Minei S, Sanaka M, Nagashima T, Yanagisawa K, Omori Y.

Endocr J. 1996 Apr;43(2):221-31.PMID: 9026269 [PubMed - indexed for MEDLINE]Related articles

Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation.

Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, Müller J, Skakkebaek NE.

J Clin Endocrinol Metab. 1995 Aug;80(8):2534-42.PMID: 7543116 [PubMed - indexed for MEDLINE]Related articles

Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis.

Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X.

J Natl Cancer Inst. 1999 Jan 20;91(2):151-6.PMID: 9923856 [PubMed - indexed for MEDLINE]Related articlesFree article